baber/WOPTO huggingface dataset:
Patent NZ-528778-A (NZ)
Title: Lactobacillus gasseri isolates that are acid- and bile salt-resistant that are able to reduce serum cholesterol
Inventor: LIU YU-JU
IPC: A61K35/747
Filed: 2003-10-09
Abstract: Disclosed are acid- and bile salt-resistant Lactobacillus isolates having the ability to lower cholesterol. The present Lactobacillus isolates or their sub-cultured offspring or mutants derived therefrom can be used in the preparation of various food products, and in the manufacture of medicaments for use in the treatment or prevention of gastrointestinal diseases and for use in lowering serum cholesterol.
Patent NZ-530917-A (NZ)
Title: Foot brace, typically for kayak, with connector allowing relative movement between connector and footrest, and connector and rail
Inventor: CHAMBERS CHRISTOPHER PAUL
IPC: B63H16/02
Filed: 2004-01-30
Abstract: A foot brace assembly has one or more foot rests 9 connected to one or more rails 1,2 via a connector so that relative motion between footrest(s) and connector, and between connector and rail(s) is provided.
Patent NZ-535113-A (NZ)
Inventor: DEZUTTER RAMON CHARLES
IPC: F26B7/00
Filed: 2004-09-06
Abstract: The pulp flaker has a housing and rotors rotating in opposite directions. Each rotor has fingers circumferentially and longitudinally arranged so that fingers of one rotor are interspaced with fingers of the other rotor.
Patent NZ-536165-A (NZ)
Title: A bracket
Inventor: SCARLETT ROYDON MARK
IPC: F16B12/00
Filed: 2004-10-27
Abstract: Disclosed is a bracket according to figure 1, having a mount (2), a hinge (3), an arm (1), and locking means; the bracket being formed such that when it is in use the mount is adjustably secured to one of several optional positions along the arm, the hinge is secured to the mount and is capable of pivoting movement about an axis or axes, the hinge and the mount being connectable at optional positions on the mount wherein in each of these positions the hinge is capable of pivoting movement with respect to the mount, and the locking means is able to lock the hinge against pivoting movement when desired; the bracket formed such that when it is in use a chair's seat can be secured to the arm at selected positions allowing for adjustment of seat depth, and a backrest of the chair can be secured to the hinge wherein the hinge can be angle adjusted and locked by the locking means to provide for angle adjustment of the backrest.
Patent NZ-536621-A (NZ)
Title: Modified release pharmaceutical formulation
Inventor: MAGNUSSON ANDERS
IPC: A61P7/10
Filed: 2003-05-27
Abstract: A modified release pharmaceutical formulation is disclosed, which comprises, as active ingredient, a pharmaceutically acceptable salt of a compound of formula (I), wherein R1 represents -CHF2 or -CH2CH2F; R2 represents hydrogen, hydroxy, methoxy or ethoxy; and n represents 0 or 2; and a pharmaceutically acceptable diluent or carrier. These modified release pharmaceutical formulations are suitable for the treatment of a cardiovascular disorder.
Patent NZ-540146-A (NZ)
Title: Supporting structures for water current (including tidal stream) turbines with elliptical support columns
Inventor: FRAENKEL PETER LEONARD
IPC: F03B17/06
Filed: 2003-11-26
Abstract: A support system for a marine turbine installation including at least one turbine unit (3), the support system including a support column (1) or two or more support columns (1) which are arranged to be installed vertically, characterised by a turbine support assembly (2/14) including a horizontally arranged turbine support structure (4/15) adapted for displacement lengthways of the associated support column or columns, at least two turbine units (3) operationally carried by the support structure and means (41/44, 26/41, 52/55, 65/66) for enabling selective displacement of the support member (4, 15) lengthways of the associated column or columns, and in that the support structure includes an elongate member profiled in such manner that when the flow of water relative to the support assembly is bi-directional, the support structure member is so profiled so as to minimise water flow disturbance what ever the direction of the bi-directional water flow.
Patent NZ-541193-A (NZ)
Title: Aminoindazole derivatives and use thereof as kinase inhibitors
Inventor: LESUISSE DOMINIQUE
IPC: C07D403/12
Filed: 2003-09-03
Abstract: Disclosed are aminoindazole derivatives having general formula (I), wherein the substituents are as defined in the specification, and the use thereof for the treatment of diseases that can result from abnormal kinase activity such as neurodegenerative diseases, strokes, cranial and spinal traumas and peripheral neuropathies, obesity, metabolic diseases, type II diabetes, essential hypertension, atherosclerotic cardiovascular diseases, polycystic ovaries syndrome, syndrome X, immunodeficiency and cancer.
Patent NZ-544016-A (NZ)
Title: Registrations in a communication system
Inventor: KISS KRISZTIAN
IPC: H04L12/56
Filed: 2004-05-11
Abstract: A method in a communication system processes incoming requests at a controller entity. The method comprises the steps of registering, in the controller entity, a plurality of contact addresses for a user, receiving a request at the controller entity for a communication link to the user, querying, by the controller entity, a user information storage for information regarding a manner regarding how to handle the request, and processing the request in accordance with the information from the user information storage.
Patent NZ-544637-A (NZ)
Title: Lipid encapsulated interfering RNA
Inventor: MACLACHLAN IAN
IPC: C12N15/113
Filed: 2004-07-16
Abstract: Provided is a nucleic acid-lipid particle, said nucleic acid-lipid particle comprising: an siRNA; a cationic lipid; a non-cationic lipid; and a conjugated lipid that inhibits aggregation of particles, wherein the conjugated lipid that inhibits aggregation of particles is a member selected from the group consisting of a polyethyleneglycol (PEG)-lipid conjugate, a polyamide (ATTA)-lipid conjugate, and combinations thereof. Further provided is the use of the composition for the formulation of a medicament for silencing expression of a target gene.
Patent NZ-551210-A (NZ)
Title: Peptide-based compounds
Inventor: CUTHBERTSON ALAN
IPC: C07K7/06
Filed: 2005-06-15
Abstract: A compound of general formula (I) and pharmaceutically acceptable salt thereof wherein: G represents glycine; D represents aspartic acid; Ra represents -(CH2)n- or -(CH2)nC6H4- wherein n represents a positive integer 1 to 10, h represents a positive integer 1 or 2; X1 represents an amino acid residue wherein said amino acid possesses a functional side-chain such as an acid or amine, X2 and X6 represent independently amino acid residues together forming a disulphide bond, X3 represents arginine, N-methylarginine or an arginine mimetic, X4 represents a thiol-containing amino acid residue, and X5 represents a hydrophobic amino acid or derivatives thereof, and X7 represents a biomodifier moiety or is absent, at least one of Z1 or Z2 is present and represents an antineoplastic agent, or an imageable moiety and W1 represents a spacer moiety or is absent.
Patent NZ-552119-A (NZ)
Title: Use of a 4-pyridylmethylphthalazines for renal cancer treatment
Inventor: DUGAN MARGARET HAN
Filed: 2002-09-11
Abstract: Disclosed is the use of a 4-pyridylmethyl-phthalazine antiangiogenic derivative for the manufacture of a pharmaceutical preparation for the treatment of renal carcinoma.
Patent NZ-554661-A (NZ)
Title: System and method for processing video images
Inventor: SPOONER DAVID A
IPC: G06T15/20
Filed: 2005-09-07
Abstract: A system for processing a video sequence, comprises a plurality of object models representing objects in the video sequence using three dimensional elements; a plurality of transform data structures defining transforms experienced by the objects between the multiple frames and a texture map generation algorithm for generating texture map data. The algorithm, for each of the object models and for each of the multiple frames, is operable to (i) identify a first portion of a respective object model that is visible according to a camera position of a current frame of the multiple frames; (ii) identify a second portion of the respective object model that is not visible according to the camera position; (iii) include graphical data from the current frame in texture map data for the first portion for the current frame; (iv) process graphical data from at least one frame other than the current frame according to a transform data structure; and (v) include the processed graphical data in texture map data for the second portion.
Patent NZ-567320-A (NZ)
Title: Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Inventor: UMANA PABLO
IPC: C12N15/62
Filed: 2004-01-22
Abstract: A method for producing a polypeptide in an isolated yeast or mammalian host cell, comprising, a. culturing an isolated yeast or mammalian host cell engineered to express at least one nucleic acid encoding a polypeptide having a-Mannosidase II activity under in vitro or ex vivo conditions which permit the production of a polypeptide selected from the group consisting of a whole antibody molecule, an antibody fragment, and a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, wherein said polypeptide having (lMannosidase II activity is expressed in an amount sufficient to modify the oligosaccharides in the Fe region ofsaid polypeptide produced by said host cell; and b. isolating said polypeptide produced by said host cell. Also disclosed are polypeptides, antibodies and fusion proteins produced by the method. The products of the method are useful in treating tumours and diseases associated with B-cell depletion. (62) Divided Out of 541503
Patent NZ-568456-A (NZ)
Title: Closure mechanism with two magnetic assemblies that are offset in alignment when the door is closed
Inventor: REDGRAVE RODERICK NIGEL
IPC: E05C19/16
Filed: 2008-05-20
Abstract: A magnetically operated closure mechanism for doors (8) and the like is disclosed. Several embodiments of the magnetically operated closure mechanism are disclosed in the disclosure in which the magnetic assemblies (1A and 1B) are adjacent but not aligned to each other when the door (8) is closed. This orientation of magnetic assemblies (1A and 1B) provides a closure mechanism in which the adjacent magnets attract each other when the door (8) is at a closer distance to the door jamb (9). The magnetic forces attract the door (8) to the jamb (9) and keeps the door (8) closed and against it.
Patent NZ-569051-A (NZ)
Title: Sewage treatment
Inventor: TAYLOR ANTHONY PATRICK ANDREW
IPC: C02F3/02
Filed: 2006-11-17
Abstract: Disclosed is a membrane comprising: a support membrane having a liquid face and a gas face; a gas face biolayer at a location selected from on the gas face, in the support membrane near the gas face, and both on the gas face and in the support membrane; and a liquid face biolayer at a location selected from on the liquid face, in the support membrane near the liquid face, and both on the liquid face and in the support membrane.
Patent NZ-576696-A (NZ)
Title: Led array with current balanced by led internal resistance
Inventor: PEAT DONALD GORDON
IPC: F21L4/00
Filed: 2010-08-04
Abstract: Disclosed is a light-emitting diode light source. The light source includes a power supply comprising a power source. An array of light-emitting diodes (D1-D46) is provided which contains a plurality of groups of light-emitting diodes (D1-D46) connected in series; the groups being connected in parallel. The light source is configured such that the internal resistance of the light emitting diodes (D1-D46) is used to at least partially balance the current distribution between the parallel groups of light emitting diodes (D1-D46).
Patent NZ-581840-A (NZ)
Title: A baker's oven having heating means underlying baking trays
Inventor: WILLETT PAUL EATON
IPC: A21B1/14
Filed: 2009-10-20
Abstract: A baking oven for improved heat distribution includes at least one insulated oven compartment; a first support means (14) within the at least one oven compartment (11) for supporting one or more baking trays above the floor; a first heating means (20) between the floor and the first support means; a second support means above the first support means; a second heating means between the first support means and the second support means; and a shield means for shielding bakery product on baking trays on the first support means from the second heating means. The first support means is rotatable relative to the first heating means and the second support means is movable relative to the second heating means. (62) Divided Out of 580537
Patent NZ-587074-A (NZ)
Title: Method of processing food material using a pulsed laser beam with an infrared wavelength
Inventor: LOESER ULRICH
IPC: A23L5/30
Filed: 2010-07-29
Abstract: A pulsed laser is used to process food material with the wavelength of the laser beam being in the near-infra red range and having a focused laser spot. The laser pulse has a pulse duration in the range 1 to 1000 fs to the food material, and the focused laser spot lies in the surface of the food material or in the body of the food material. The laser pulse creates a cavity in the food material at the position of the laser spot.
Patent NZ-593272-A (NZ)
Title: Breathing pipe with compartment having moutpiece and fan drivingly connected to a fan in another separated compartment to force air with active substance to outlet, typically near users nose to avoid nuisance to others
Inventor: PEARSON SCOTT
IPC: A61M16/00
Filed: 2011-06-07
Abstract: The breathing apparatus, typically configured as a breathing pipe, has two separated compartments so that a user inhaling through the mouthpiece causes fan blades in one compartment to rotate on a shaft which is drivingly connected to a shaft and fan blades in the other compartment so as to cause an air with an active substance to be delivered in the vicinity of the user's nostrils. This is stated to have a calming effect on a user.
Patent NZ-596901-A (NZ)
Title: A method of determing an amount to be repaid at an early conclusion of a financing arrangement prior to a maximum permissible term of the financing arrangement
Inventor: JOYE CHRISTOPER RONALD EDWARD
IPC: G06Q40/00
Filed: 2005-10-13
Abstract: 596901 A method of generating a digitally encoded electronic signal representing an amount to be repaid at an early conclusion of a financing arrangement prior to a maximum permissible term of the financing arrangement is disclosed. The financing arrangement is wholly or partially secured by a collateral asset. Input data comprising an initial value of the collateral asset at the commencement of the financing arrangement, or at a time proximate thereto; a concluding value of the collateral asset at the conclusion of the financing arrangement, or at a time proximate thereto; a principal value being an amount advanced at the commencement of the financing arrangement; a first predetermined share; and a second predetermined share is inputted into data processing apparatus. The data processing apparatus is instructed to calculate the amount to be repaid at the conclusion of the financing arrangement. The amount comprises the principal value plus, if the concluding value exceeds the initial value, the first predetermined share of the excess of the concluding value over the initial value less, if the concluding value does not exceed the initial value, the second predetermined share of the deficit of the concluding value relative to the initial value. The data processing apparatus is instructed to output a digitally encoded electric signal comprising the value of the amount to be repaid.
Patent NZ-597963-A (NZ)
Title: A pharmaceutical formulation comprising n-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-n’-(1,1-dimethylethyl)-urea in the form of a base or a salt thereof
Inventor: BURNOUF JEAN-PIERRE
IPC: A61K47/14
Filed: 2010-07-29
Abstract: 597963 Disclosed is a pharmaceutical formulation comprising N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N’-(1,1-dimethylethyl)-urea (formula (I)), in the form of a base or in the form of a salt of an acid which is pharmaceutically acceptable, solubilized in a mixture of ethanol and of the surfactant macrogol 15 hydroxystearate in a surfactant/ethanol ratio by weight ranging from 25/75 to 80/20.
Patent NZ-599096-A (NZ)
Title: Washer assembly for variable alignment of a threaded fastener
Inventor: BURKE JOHN THOMAS
IPC: E04B1/41
Filed: 2010-11-04
Abstract: 599096Acombinationofawasherassemblyandathreadedfastener(38)isdisclosed.Theassemblyincludesafirstwasherportion(23)withanapertureforthethreadedfastener(38)andasecondwasherportion(24)withanaperture(29)forthefastener.Thefirstandsecondportionshaveopposingsurfacesthatareurgedintocontactupontensioningofthefastener(38).Thesurfaceshaveco-operatingprojectionsandrecessesthatinhibitrelativemovementbetweenthewasherportions.Theaperturesaredimensionedtoproviderelativemovementbetweentheportionswhentheaperturesarealignedtoallowfortheinsertionofthethreadedfastener(38).Thethreadedfastener(38)includesanarcuatesurface(51)toengagethesecondwasherportion(24)adjacenttheaperture(29).Useofthewasherandfastenerassemblytosecureconcreteelementsisalsodisclosed.
Patent NZ-601217-A (NZ)
Title: Apparatus for modified atmosphere packaging of products placed in trays
Inventor: VACCARI MASSIMILIANO
IPC: B65B31/02
Filed: 2011-01-20
Abstract: 601217 An apparatus for the modified atmosphere packaging of products placed in trays, of the type comprising opposing housings, namely an upper housing 1 containing the welding means 5 and the cutting means 6 for use on the barrier film for sealing the trays, and an upwardly open lower housing 18 with a chamber 19 for housing the trays V which can be moved into and out of this chamber by suitable means, and comprising means for positioning a stretched portion of film F between the two housings and above the trays, as well as means for bringing the housings towards each other to clamp between them the edges of the tray and the film above these edges, and also comprising means for extracting air from the tray and subsequently injecting process gases into the tray to preserve the product placed therein, before the subsequent step of welding the film to the edge of the tray and the subsequent cut along the perimeter of the portion of film welded to the tray. There is provided, between the two housings 18, and below and parallel to the film F, a frame 7 having openings 8 with shapes and dimensions suitably greater than the shapes and dimensions in plan view of the underlying trays V to be packaged, supported by any means such that, during the closure of the housings 18. This frame 7 interacts with its own sealing means and/or those of the housings to form a main chamber delimited by the upper edge of the tray and by the film above this edge. This chamber is initially connected to the inner chambers 19 of the two housings 18, for the step of removing the air from these chambers and forming the desired degree of vacuum. In a subsequent step, the main chamber is isolated by suitable means from the inner chambers of the two housings, so that the process gases for preserving the product can be injected directly into this main chamber through a dedicated circuit connected to it, while a suitable quantity of atmospheric air is directed into the inner chambers of the housings 18 to counterbalance the pressures on the opposite faces of the film. When the process gases have been fed in the film is welded in a sealed way to the edge of the tray and is cut outside this edge by a cutter 6 associated with the upper housing. The whole arrangement is such that, at the end of the cycle, when the housings 18 are opened, no large quantities of process gases are dispersed into the atmosphere, as would be the case in the prior art.
Patent NZ-603643-A (NZ)
Title: Purinone derivative
Inventor: YAMAMOTO SHINGO
IPC: C07D473/34
Filed: 2011-05-30
Abstract: 603643 Disclosed are 6-amino-9-[heterocyclyl]-7-(phenyl)-7,9-dihydro-8H-purin-8-one derivatives as represented by general formula (I), wherein: ring1 represents a 4- to 7-membered cyclic group, which may be substituted by from one to five substituents each independently selected from the group consisting of halogen, alkyl, alkoxy, nitrile, haloalkyl and haloalkoxy, wherein when two or more substituents are present on ring1, these substituents may form a 4- to 7-membered cyclic group together with the atoms in ring1 to which these substituents are bound; ring2 represents a 4- to 7-membered saturated heterocycle, which is substituted by from one to three K-R2; K represents -CO-; R2 represents a C2-4 alkenyl group or a C2-4 alkynyl group, each of which may be substituted by from one to five substituents; n represents an integer from 0 to 4; m represents an integer from 0 to 2; an optical isomer thereof or their mixture, a salt thereof, a solvate thereof, an N-oxide thereof, or a prodrug thereof. Representative compounds include 9-(1-acryloyl-3-azetidinyl)-6-amino-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; 6-amino-9-{ (3R)-1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-pyrrolidinyl} -7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; 9-[(1-acryloyl-4-piperidinyl)methyl]-6-amino-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; 6-amino-9-[(3R)-1-(2-butynoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; 6-amino-9-{ (3S)-1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-pyrrolidinyl} -7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; 6-amino-7-[4-(3-chlorophenoxy)phenyl]-9-{ (3R)-1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-pyrrolidinyl} -7,9-dihydro-8H-purin-8-one; 6-amino-9-[1-(2-butynoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; or 6-amino-9-{ 1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-pyrrolidinyl} -7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one, or an optical isomer thereof or their mixture. Further disclosed is a pharmaceutical composition comprising a compound represented by general formula (I) as defined above, for the treatment of Btk-related diseases such as allergic diseases, autoimmune diseases, inflammatory diseases, thromboembolic diseases, or cancer.
Patent NZ-607012-A (NZ)
Title: A driver related data storage system and method
Inventor: AOYAGI KENICHIRO
IPC: H04W48/02
Filed: 2012-12-20
Abstract: 607012 Disclosed is a communication system which includes a mobile device (300) connectable to a
Patent NZ-609151-A (NZ)
Title: 4-(methylaminophenoxy)pyridin-3-yl-benzamide derivatives for treating cancer
Inventor: NAKAGAWA TAKASHI
IPC: A61K31/44
Filed: 2011-10-03
Abstract: Provided are 4-(methylaminophenoxy)pyridin-3-yl-benzamide derivative compounds, of general formula (1), wherein R1, R2 and m are as described in the specification. A preferred compound is N-{ 6-[2-fluoro-4-(methylamino)phenoxy]pyridin-3 -yl} -4-phenoxybenzamide. The compounds are anticancer agents. Further provided are pharmaceutical compositions comprising the compounds and uses of the compounds.
Patent NZ-628246-A (NZ)
Title: Lever viscoelastic damping wall assembly
Inventor: TSUANG STEVEN
IPC: F16F15/04
Filed: 2014-08-04
Abstract: A lever viscoelastic damping wall assembly includes a first wall, a second wall and a viscoelastic damper. The first and second walls are connected respectively to a first structural member and a second structural member. The viscoelastic damper includes a swing rod connected pivotally to the first and second walls, a first viscoelastic unit connected between the first wall and an end portion of the swing rod, and a second viscoelastic unit connected between the second wall and an opposite end portion of the swing rod. The swing rod is driven to pivot relative to the first and second walls, and to thereby generate shear deformations of the first and second viscoelastic units to damp a relative movement between the first and second structural members. Other embodiments are disclosed.